These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1846388

  • 1. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
    Mester JC, Glorioso JC, Rouse BT.
    J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 3. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L, Paz P, Navarro D, Pereira L, Kohl S.
    J Infect Dis; 1992 Sep 01; 166(3):623-7. PubMed ID: 1380051
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
    Kohl S, Strynadka NC, Hodges RS, Pereira L.
    J Clin Invest; 1990 Jul 01; 86(1):273-8. PubMed ID: 2164044
    [Abstract] [Full Text] [Related]

  • 5. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC.
    J Virol; 1985 Dec 01; 56(3):930-7. PubMed ID: 2415719
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M, Petríková M, Zatovicová M, Soláriková L, Kostolanský F, Mucha V, Russ G.
    Acta Virol; 1997 Feb 01; 41(1):5-12. PubMed ID: 9199708
    [Abstract] [Full Text] [Related]

  • 7. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL, Duncan BE, Raybould TJ, Watson DH.
    J Gen Virol; 1985 May 01; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [Abstract] [Full Text] [Related]

  • 8. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.
    Balachandran N, Bacchetti S, Rawls WE.
    Infect Immun; 1982 Sep 01; 37(3):1132-7. PubMed ID: 6290390
    [Abstract] [Full Text] [Related]

  • 9. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL, Lukig ML, Liew FY.
    J Exp Med; 1985 Oct 01; 162(4):1304-18. PubMed ID: 2995536
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
    Fujinaga S, Sugano T, Matsumoto Y, Masuho Y, Mori R.
    J Infect Dis; 1987 Jan 01; 155(1):45-53. PubMed ID: 3025308
    [Abstract] [Full Text] [Related]

  • 11. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.
    Mester JC, Highlander SL, Osmand AP, Glorioso JC, Rouse BT.
    J Virol; 1990 Nov 01; 64(11):5277-83. PubMed ID: 1698994
    [Abstract] [Full Text] [Related]

  • 12. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.
    Rector JT, Lausch RN, Oakes JE.
    Infect Immun; 1982 Oct 01; 38(1):168-74. PubMed ID: 6292092
    [Abstract] [Full Text] [Related]

  • 13. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S, Loo LS.
    J Immunol; 1982 Jul 01; 129(1):370-6. PubMed ID: 6282968
    [Abstract] [Full Text] [Related]

  • 14. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Nov 01; 88(21):12612-22. PubMed ID: 25142599
    [Abstract] [Full Text] [Related]

  • 15. Passive immune protection by herpes simplex virus-specific monoclonal antibodies with different plaque development inhibition activity.
    Mannini-Palenzona A, Costanzo F, Cassai E, Campana G.
    New Microbiol; 1993 Jul 01; 16(3):205-13. PubMed ID: 8396193
    [Abstract] [Full Text] [Related]

  • 16. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
    Dix RD, Pereira L, Baringer JR.
    Infect Immun; 1981 Oct 01; 34(1):192-9. PubMed ID: 6271681
    [Abstract] [Full Text] [Related]

  • 17. Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infection.
    Bernstein DI, Loo LS, Kohl S.
    Antiviral Res; 1988 Dec 11; 10(6):279-87. PubMed ID: 2854958
    [Abstract] [Full Text] [Related]

  • 18. HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses.
    Burn Aschner C, Loh LN, Galen B, Delwel I, Jangra RK, Garforth SJ, Chandran K, Almo S, Jacobs WR, Ware CF, Herold BC.
    Sci Immunol; 2020 Aug 14; 5(50):. PubMed ID: 32817296
    [Abstract] [Full Text] [Related]

  • 19. Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2.
    Kao CM, Goymer J, Loh LN, Mahant A, Burn Aschner C, Herold BC.
    J Infect Dis; 2020 Feb 18; 221(5):729-738. PubMed ID: 31599942
    [Abstract] [Full Text] [Related]

  • 20. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 18; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.